Literature DB >> 10436294

Tobacco cessation among patients with depression.

L S Covey1.   

Abstract

This article summarizes the research evidence on the association between smoking and depression. Across multiple studies and clinical and population-based samples, it has been demonstrated that, compared with nondepressed individuals, persons with depression are more likely to be smokers, to be dependent smokers, to have difficulty stopping smoking, and to experience more severe withdrawal symptoms. Further, they may be at risk of experiencing severe depression once they have stopped smoking. Based on the author's experience with this population of smokers, recommendations for assessing smokers' vulnerability to depression, their level of nicotine dependence, and psychological and pharmacological aids for smokers are offered.

Entities:  

Mesh:

Year:  1999        PMID: 10436294     DOI: 10.1016/s0095-4543(05)70124-x

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  27 in total

1.  Tobacco use among adults with disabilities in Massachusetts.

Authors:  Phyllis Brawarsky; D R Brooks; N Wilber; R E Gertz; D Klein Walker
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

2.  Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.

Authors:  Sarah E Evans; Melissa Blank; Cynthia Sams; Michael F Weaver; Thomas Eissenberg
Journal:  Exp Clin Psychopharmacol       Date:  2006-05       Impact factor: 3.157

Review 3.  Applying the tripartite model of anxiety and depression to cigarette smoking: an integrative review.

Authors:  Katherine J Ameringer; Adam M Leventhal
Journal:  Nicotine Tob Res       Date:  2010-10-29       Impact factor: 4.244

Review 4.  Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.

Authors:  Linda P Dwoskin; Anthony S Rauhut; Kelley A King-Pospisil; Michael T Bardo
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

5.  The novel nicotinic receptor antagonist, N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide (bPiDDB), inhibits nicotine-evoked [(3)H]norepinephrine overflow from rat hippocampal slices.

Authors:  Andrew M Smith; Gurpreet K Dhawan; Zhenfa Zhang; Kiran B Siripurapu; Peter A Crooks; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2009-07-23       Impact factor: 5.858

6.  Attenuated beta endorphin response to acute stress is associated with smoking relapse.

Authors:  Darcy Shaw; Mustafa al'Absi
Journal:  Pharmacol Biochem Behav       Date:  2008-04-03       Impact factor: 3.533

Review 7.  Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease.

Authors:  Edwin J Wagena; Maurice P A Zeegers; Constant P van Schayck; Emiel F M Wouters
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Bupropion and cognitive-behavioral treatment for depression in smoking cessation.

Authors:  Richard A Brown; Raymond Niaura; Elizabeth E Lloyd-Richardson; David R Strong; Christopher W Kahler; Ana M Abrantes; David Abrams; Ivan W Miller
Journal:  Nicotine Tob Res       Date:  2007-07       Impact factor: 4.244

9.  Psychological distress and depressed mood in employees with asthma, chronic bronchitis or emphysema: a population-based observational study on prevalence and the relationship with smoking cigarettes.

Authors:  Edwin J Wagena; Ijmert Kant; Marcus J H Huibers; Ludovic G P M van Amelsvoort; Gerard M H Swaen; Emiel F M Wouters; Constant P van Schayck
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

10.  Psychiatric disorders in smokers seeking treatment for tobacco dependence: relations with tobacco dependence and cessation.

Authors:  Megan E Piper; Stevens S Smith; Tanya R Schlam; Michael F Fleming; Amy A Bittrich; Jennifer L Brown; Cathlyn J Leitzke; Mark E Zehner; Michael C Fiore; Timothy B Baker
Journal:  J Consult Clin Psychol       Date:  2010-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.